Literature DB >> 3321938

An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial.

J Holmgren1, A M Svennerholm, J Clemens, D Sack, R Black, M Levine.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3321938

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  History of vaccination.

Authors:  Stanley Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

3.  Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.

Authors:  M R Fontana; R Manetti; V Giannelli; C Magagnoli; A Marchini; R Olivieri; M Domenighini; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 4.  Overview of vaccines.

Authors:  G Ada
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

5.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

6.  The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides.

Authors:  Jyoti Mathur; Matthew K Waldor
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.